COMMUNIQUÉS West-GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08/05/2026 -
Shiny Smile Veneers Under Investigation: Evaluating the Dentist-Designed Custom Fit Snap-On Top & Bottom Veneer Claims
08/05/2026 -
Fitness Online Named “Best Fitness Mobile App” in 10th Annual MedTech Breakthrough Awards Program
08/05/2026 -
Major Shareholder Announcement
08/05/2026 -
Her Bodhi Claims Evaluated: Meno & Hormonal Support for Women by HerBodhi Under Investigation
08/05/2026 -
More Life Summit 2026 Brings the World's Leading Voices in Longevity, Performance, Faith & Purpose to Miami this October
08/05/2026 -
Erdem Health Group Enters Türkiye’s TURQUALITY Program
08/05/2026 -
Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million
08/05/2026 -
Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights
08/05/2026 -
MapLight Therapeutics to Participate in Upcoming Investor Conferences
08/05/2026 -
Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update
08/05/2026 -
Global Ovarian Cancer Research Consortium Announces Next AI Accelerator Grant to Advance Data-Driven Discovery
08/05/2026 -
Le Consortium international de recherche sur le cancer de l’ovaire annonce une nouvelle bourse pour des recherches propulsées par l’IA, visant à faire progresser les découvertes fondées sur les données
08/05/2026 -
Merit Medical to Participate in the Bank of America Healthcare Conference
08/05/2026 -
ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology
08/05/2026 -
Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma
08/05/2026 -
Philips shareholders approve all proposals at the AGM 2026
08/05/2026 -
Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma
08/05/2026 -
J-Star Holding Signs MOU with White Group to Advance Financing for Texas Solid-State Battery Facility
08/05/2026
Pages